Live from the NIH registry
Studies recruiting near Richmond right now
Top 25 of 599 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Bon Secours Richmond Community Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
VCU — Richmond, Virginia (1.9 mi)
· Sponsor: AskBio Inc
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Giselle Sholler
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
VCU Massey Comprehensive Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Breast Cancer
Phase 2
Interventional 170 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Virginia Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: Dosentrx Ltd.
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Richmond, Virginia (1.9 mi)
· Sponsor: Xencor, Inc.
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
VCU Health Adult Outpatient Pavillion ( Site 0138) — Richmond, Virginia (1.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Richmond, Virginia (1.9 mi)
· Sponsor: Sameek Roychowdhury
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Heart Failure, Congestive, Death, Sudden, Cardiac
N/A
Observational 1,500 participants sought
Virginia Commonwealth University School of Medicine — Richmond, Virginia (1.9 mi)
· Sponsor: Johns Hopkins University
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Institute of Virginia — Richmond, Virginia (1.9 mi)
· Sponsor: Genentech, Inc.
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Henrico Doctor's Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Congenital Myotonic Dystrophy, CDM
N/A
Observational 50 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
Motor Adaptation and Generalization, Posterior Parietal Cortex
N/A
Interventional 60 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Richmond, Virginia (1.9 mi)
· Sponsor: AstraZeneca
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Richmond, Virginia (1.9 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Bon Secours Richmond Community Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: NRG Oncology
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Virginia Commonwealth University - Massey — Richmond, Virginia (1.9 mi)
· Sponsor: NSABP Foundation Inc
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0337 — Richmond, Virginia (1.9 mi)
· Sponsor: Bristol-Myers Squibb
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Hunter Holmes McGuire VA Medical Center, Richmond, VA — Richmond, Virginia (1.9 mi)
· Sponsor: VA Office of Research and Development
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Hunter Holmes McGuire VA — Richmond, Virginia (1.9 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Multiple conditions
Phase 1
Interventional 46 participants sought
VCU Massey Comprehensive Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 255 participants sought
Research Site — Richmond, Virginia (1.9 mi)
· Sponsor: AstraZeneca
Psychobiological Responses Following Exercise and Brain Stimulation
Psychological
N/A
Interventional 29 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University